CIS administration caused considerable liver and kidney damage, as evidenced by elevated serum levels of BUN, AST, ALT, ALP, and creatinine, which are key biomarkers of hepatotoxicity and nephrotoxicity (Elhady et al. 2022). Here, GPT is linked to in situ carcinoma.